Scholar Rock Announces New Employee Grants under Nasdaq Rule 5635(c)(4)
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical firm focused on innovative treatments for spinal muscular atrophy and other serious conditions, announced granting inducement equity awards to two new employees. These awards consist of stock options for 25,714 shares and restricted…
Research Antibodies & Reagents Market Trends: 2023 & Beyond
The latest addition to ResearchAndMarkets.com’s offerings: Global Research Antibodies & Reagents Market Forecast 2024-2029. The Global Research Antibodies & Reagents Market witnessed a valuation of USD 13.39 billion in 2023, with projections to reach USD 21.28 billion by 2029, marking…
TheracosBio’s BRENZAVVY® Matches Dapagliflozin in Chinese Type 2 Diabetes Study
Today, TheracosBio announced the publication of a study in the Journal of Diabetes titled “Comparison of Bexagliflozin with Dapagliflozin as an Adjunct to Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A 24-week Phase 3 Trial.” The study, conducted…
HeartBeam AI Shows Promising Arrhythmia Detection Results
Today, HeartBeam, Inc. (NASDAQ: BEAT), a medical technology firm dedicated to revolutionizing cardiac care with personalized insights, revealed new findings indicating significant improvements in atrial flutter detection by employing the company’s artificial intelligence (AI) algorithms on vectorcardiography (VCG). The results…
CHARME Initiative Targets Healthcare Emissions
Today marks the launch of the Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative, aiming to slash greenhouse gas emissions from the U.S. medical device and equipment supply chain. The MedTech supply chain contributes to 7% of U.S. healthcare…
InfoBionic rebrands to ‘InfoBionic.Ai’, emphasizing AI-driven ECG focus.
Today, InfoBionic.Ai, a digital health firm offering AI-driven diagnostic remote patient monitoring solutions, announced a name change from ‘InfoBionic’ to ‘InfoBionic.Ai.’ This shift underscores the company’s ongoing dedication to harnessing artificial intelligence in virtual cardiac care. InfoBionic has long been…
S2 Genomics Unveils Innovative Single Cell FFPE Sample Prep Solution
S2 Genomics, a leading innovator in tissue sample preparation systems, has unveiled its latest groundbreaking product, the Singulator™ 200+ System. This state-of-the-art technology represents a significant advancement in automated sample preparation specifically designed for single-cell formalin-fixed, paraffin-embedded (FFPE) tissues. By…
Transcat Inc. Reveals Changes in Executive Leadership
Transcat Inc. (NASDAQ:TRNS), a prominent provider of accredited calibration services and value-added rental/distribution of professional-grade handheld test, measurement, and control instrumentation, has declared that Mark Doheny will resign from his position as Chief Operating Officer, effective immediately. Mr. Doheny will…
Bayer, Google Cloud Partner for AI Healthcare Apps in Radiology
Bayer and Google Cloud have joined forces to advance artificial intelligence (AI) solutions for supporting radiologists and enhancing patient care. Leveraging Google Cloud’s technology, including its generative AI (gen AI) tools, Bayer will enhance its innovation platform to expedite the…
SimBioSys Introduces TumorSight Plan: Clinical Support for Early-Stage Breast Cancer
SimBioSys®, an innovative TechBio firm harnessing spatial biophysics with artificial intelligence (AI) and computational modeling to revolutionize precision medicine in cancer, is thrilled to unveil its latest clinical offering, TumorSight Plan. This groundbreaking application is the first of its kind,…
HealthLock Appoints New CRO and CGO to Meet Demand, Shape Customer Experience
HealthLock, a prominent solution in medical fraud and overbilling protection, has appointed two experienced executives to its leadership team: Adam Hewitt as Chief Revenue Officer (CRO) and David Putnam as Chief Growth Officer (CGO). In their roles, both leaders will…
Q Bio Reveals Tensor Field Mapping: Advancing MRI Measurement
Today, Q Bio Inc., a trailblazer in medical imaging technology, introduced Tensor Field Mapping (TFM), a cutting-edge advancement in Magnetic Resonance Imaging (MRI). TFM offers unprecedented insights into the human body, providing quantitative imaging data that surpasses the qualitative data…